MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10120-017-0746-1

Медицинская библиотека · Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2017

Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?

Blank Susanne, Schmidt Thomas, Heger Patrick, Strowitzki Moritz J, Sisic Leila, Heger Ulrike, Nienhueser Henrik, Haag Georg Martin, Bruckner Thomas, Mihaljevic André L, Ott Katja, Büchler Markus W, Ulrich Alexis

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The optimal surgical approach for adenocarcinoma directly at the esophagogastric junction (AEG II) is still under debate. This study aims to evaluate the differences between right thoracoabdominal esophagectomy (TAE) (Ivor-Lewis operation) and transhiatal extended gastrectomy (THG) for AEG II.

METHODS

From a prospective database, 242 patients with AEG II (TAE, n = 56; THG, n = 186) were included and analyzed according to characteristics and perioperative morbidity and mortality and overall survival (chi-square, Mann-Whitney U, log-rank, Cox regression).

RESULTS

Groups were comparable at baseline with exception of age. Patients older than 70 years were more frequently resected by THG (p = 0.003). No differences in perioperative morbidity (p = 0.197) and mortality (p = 0.711) were observed, including anastomotic leakages (p = 0.625) and pulmonary complications (p = 0.494). There was no significant difference in R0 resection (p = 0.719) and number of resected lymph nodes (p = 0.202). Overall median survival was 38.4 months. Survival after TAE was significantly longer than after THG (median OS not reached versus 33.6 months, p = 0.02). Multivariate analysis revealed pN-category (p < 0.001) and type of surgery (p = 0.017) as independent prognostic factors. The type of surgery was confirmed as prognostic factor in locally advanced AEG II (cT 3/4 or cN1), but not in cT1/2 and cN0 patients.

CONCLUSIONS

Our single-center experience suggests that patients with (locally advanced) AEG II tumors may benefit from TAE compared to THG. For further evaluation, a randomized trial would be necessary.

Для цитирования: Blank Susanne, Schmidt Thomas, Heger Patrick, Strowitzki Moritz J, Sisic Leila, Heger Ulrike, Nienhueser Henrik, Haag Georg Martin, Bruckner Thomas, Mihaljevic André L, Ott Katja, Büchler Markus W, Ulrich Alexis. Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2017. DOI: 10.1007/s10120-017-0746-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.